Photodynamic therapy (PDT) is an effective noninvasive therapeutic strategy that can convert oxygen to highly cytotoxic singlet oxygen (O) through the co-localization of excitation light and photosensitizers. However, compromised by the hypoxic tumor microenvironment, the therapeutic efficacy of PDT is reduced seriously. Herein, to overcome tumor-associated hypoxia, and further achieve tumor-targeted synergistic chemotherapy/PDT/photothermal therapy (PTT), we have constructed a biodegradable oxygen-producing nanoplatform (named Ini@PM-HP), which was composed of the porous metal-organic framework (PCN-224(Mn)), the poly (ADP-ribose) polymerase (PARP) inhibitor (Iniparib), and the polydopamine-modified hyaluronic acid (HA-PDA). Since HA can specifically bind to the overexpressed HA receptors (cluster determinant 44, CD44) on tumor cell, Ini@PM-HP prefers to accumulate at the tumor site once injected intravenously. Then iniparib can be released in tumor environment (TME), thereby dysfunctioning DNA damage repair and promoting cell apoptosis. At the same time, the chelating of Mn and tetrakis(4-carboxyphenyl) porphyrin (Mn-TCPP) can generate O in situ by reacting with endogenous HO, relieving the hypoxic TME and achieving enhanced PDT. Moreover, owing to the high photothermal conversion efficiency of PDA, PTT can be driven by the 808 nm laser irradiation. As systematically demonstrated in vitro and in vivo, this nanotherapeutic approach enables the combined therapy with great inhibition on tumor. Overall, the as-prepared nanoplatform provide a promising strategy to overcome tumor-associated hypoxia, and shows great potential for combination tumor therapy. STATEMENT OF SIGNIFICANCE: A delicately designed biodegradable oxygen-producing nanoplatform Ini@PM-HP is constructed to achieve combination therapy of solid tumors. Taking advantage of the active-targeting, PTT, enhanced PDT and PARPi, this nanotherapeutic approach successfully enables the combined chemo/photothermal/photodynamic therapy with great inhibition of solid tumors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.actbio.2021.10.032 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Roles of Mitochondria in Human Being's Life and Aging.
Biomolecules
October 2024
School of Allied Health Sciences, Walailak University, Thasala 80161, Thailand.
The universe began 13.8 billion years ago, and Earth was born 4.6 billion years ago.
View Article and Find Full Text PDFUnveiling the influence of oxygen on drug release dynamics in semipermeable polymersomes.
Angew Chem Int Ed Engl
October 2024
Department of Biomedical Engineering, Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherland.
Semipermeable polymersomes, a class of polymeric vesicles that allow molecular passage across their membranes, offer significant potential for controlled drug delivery. These vesicles can be designed for inherent or selective permeability through the choice of suitable copolymers or the incorporation of protein nanopores, respectively. In this study, we explore a novel approach using oxygen-producing enzymatic reactions within biodegradable poly(ethylene glycol)-poly(caprolactone-gradient-trimethylene carbonate) (PEG-p(CL-g-TMC)) polymersomes to modulate drug release.
View Article and Find Full Text PDFMulti-functional nanosonosensitizer-engineered bacteria to overcome tumor hypoxia for enhanced sonodynamic therapy.
Acta Biomater
November 2024
Key Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, Hengyang Medical School, University of South China, Changsha, PR China; Institute of Medical Imaging, Hengyang Medical School, University of South China, Hengyang, PR China; Department of Medical Imaging, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, PR China. Electronic address:
Article Synopsis
- - The study introduces a new biohybrid system, CB@HPP, that combines genetically engineered bacteria with nanosonosensitizers to improve sonodynamic therapy (SDT) for tumors by addressing challenges like tumor hypoxia and treatment timing.
- - CB@HPP demonstrated effective targeting of tumor tissue and enhanced oxygen production, which alleviated intratumoral hypoxia, thereby boosting the effectiveness of SDT.
- - With its multimodal imaging capabilities, CB@HPP not only helps visualize tumor targeting but also supports timely and effective antitumor treatment, making it a promising strategy for cancer therapy.
Widespread occurrence of dissolved oxygen anomalies, aerobic microbes, and oxygen-producing metabolic pathways in apparently anoxic environments.
FEMS Microbiol Ecol
October 2024
School of Life Sciences, University of Nevada Las Vegas, Las Vegas, NV 89119, United States.
Nearly all molecular oxygen (O2) on Earth is produced via oxygenic photosynthesis by plants or photosynthetically active microorganisms. Light-independent O2 production, which occurs both abiotically, e.g.
View Article and Find Full Text PDFCatalase: A Potential Pharmacologic Target for Hydrogen Peroxide in the Treatment of COVID-19.
Curr Top Med Chem
October 2024
Department of Neuropharmacology, Institute of Experimental Medicine, Saint Petersburg, Russia.
Background: Acute respiratory distress syndrome in the elderly with COVID-19 complicated by airway obstruction with sputum and mucus, and cases of asphyxia with blood, serous fluid, pus, or meconium in newborns and people of different ages can sometimes cause hypoxemia and death from hypoxic damage to brain cells, because the medical standard does not include intrapulmonary injections of oxygen-producing solutions. The physical-chemical repurposing of hydrogen peroxide from an antiseptic to an oxygen-producing antihypoxant offers hope for the development of new drugs.
Methods: This manuscript is a meta-analysis performed according to PRISMA guidelines.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!